Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma

Cell

Volumn 88, Issue 6, 1997, Pages 801-810

  Dong, Zhongyun ^a   Kumar, Rakesh ^a   Yang, Xiulan ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; ELASTASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; LEWIS CARCINOMA; LUNG METASTASIS; LUNG WEIGHT; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0030998660     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81926-1     Document Type: Article

References (62)

1. Aukerman, S.L., Price, J.E., and Fidler, I.J. (1986). Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735 melanoma cells from producing metastases. J. Natl. Cancer Inst. 77, 915-924.
2. Austyn, J.M., and Gordon, S. (1981). F4/80, a monoclonal antibody directed specifically against the mouse macrophages. Eur. J. Immunol. 11, 805-815.
3. Banda, M.J., and Werb, Z. (1981). Mouse macrophage elastase: purification and characterization as a metalloproteinase. Biochem. J. 193, 589-605.
4. Banda, M.J., Clark, E.J., and Werb, Z. (1980). Limited proteolysis by macrophage elastase inactivates human alpha 1-proteinase inhibitor. J. Exp. Med. 152, 1563-1570.
5. Banda, M.J., Clark, E.J., and Werb, Z. (1983). Selective proteolysis of immunoglobulins by mouse macrophage elastase. J. Exp. Med. 157, 1184-1196.
6. Belaaouaj, A., Shipley, J.M., Kobayashi, O.K., Zimonjic, D.B., Popescu, N., Silverman, G.A., and Shapiro, S.D. (1995). Human macrophage metalloelastase: genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J. Biol. Chem. 270, 14568-14575.
7. Bucana, C.D., Fabra, A., Sanchez, R., and Fidler, I.J. (1992). Different patterns of macrophage infiltration into allogeneic-murine and xenogeneic-human neoplasms growing in nude mice. Am. J. Pathol. 141, 1225-1236.
8. Busiek, D.F., Ross, P., McDonnell, S., Murphy, G., Matrisian, L.M., and Welgus, H.G. (1992). The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J. Biol. Chem. 267, 9087-9092.
9. Dong, Z., Qi, X., and Fidler, I.J. (1993). Tyrosine phosphorylation of MAP kinase is necessary for activation of murine macrophages by natural and synthetic bacterial products. J. Exp. Med. 173, 1071-1077.
10. Dong, Z., Radinsky, R., Fan, D., Tsan, R., Bucana, C.D., Wilmanns, C., and Fidler, I.J. (1994). Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J. Natl. Cancer Inst. 86, 913-920.
11. Dong, Z., Yang, X., Xie, K., Juang, S., Llansa, N., and Fidler, I.J. (1995). Activation of inducible nitric oxide synthase gene in murine macrophages requires protein phosphatases-1 and 2-A activities. J. Leukoc. Biol. 58, 725-732.
12. Fidler, I.J. (1985). Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res. 45, 4714-4726.
13. Fidler, I.J. (1990). Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes memorial award lecture. Cancer Res. 50, 6130-6138.
14. Fidler, I.J. (1994). Therapy of cancer metastasis by systemic activation of macrophages. Adv. Pharmacol. 30, 271-326.
15. Fidler, I.J. (1995). Modulation of the organ microenvironment for the treatment of cancer metastasis [commentary]. J. Natl. Cancer Inst. 87, 1588-1592.
16. Fidler, I.J., and Ellis, L.M. (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188.
17. Fidler, I.J., and Schroit, A.J. (1988). Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim. Biophys. Acta 948, 151-173.
18. Fisher, B., Gunduz, N., Coyle, J., Ruddock, C., and Saffer, E. (1989). Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 49, 1996-2001.
19. Gately, S., Twardowski, P., Stack, M.S., Patrick, M., Boggio, L., Cundiff, D.L., Schnaper, H.W., Madison, L., Volpert, O., Bouck, N., et al. (1996). Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res. 56, 4887-4890.
20. Gorelik, E. (1983a). Concomitant tumor immunity and the resistance to a second tumor challenge. Adv. Cancer Res. 39, 71-120.
21. Gorelik, E. (1983b). Resistance of tumor-bearing mice to a second tumor challenge. Cancer Res. 43, 138-145.
22. Gorelik, E., Segal, S., and Feldman, M. (1978). Growth of a local tumor exerts a specific inhibitory effect on progression of lung metastasis. Int. J. Cancer 21, 617-625.
23. Gorelik, E., Segal, S., and Feldman, M. (1980). Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity. J. Natl. Cancer Inst. 65, 1257-1264.
24. Gorelik, E., Segal, S., and Feldman, M. (1981). On the mechanism of tumor "concomitant immunity." Int. J. Cancer 27, 847-856.
25. Holmgren, L., O'Reilly, M.S., and Folkman, J. (1995). Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149-153.
26. Jones, P.D. E., and Castro, J.E. (1977). Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum. Br. J. Cancer 35, 519-527.
27. Katsuda, S., Okada, Y., Okada, Y., Imai, K., and Nakanishi, I. (1994). Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B)can degrade arterial elastin. Am. J. Pathol. 145, 1208-1218.
28. Keller, R. (1982). Mononuclear phagocytes in the control of primary and secondary tumor growth. Adv. Exp. Med. Biol. 155, 289-302.
29. Kumar, R., Dong, Z., and Fidler, I.J. (1996). Differential regulation of metalloelastase activity in murine peritoneal macrophages by GM-CSF and M-CSF. J. Immunol. 157, 5104-5111.
30. Lacraz, S., Nicod, L., Rochemonteix, B.G., Baumberger, C., Dayer, J., and Welgus, H. (1992). Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90, 382-388.
31. Levy, AT., Cioce, V., Sobel, M.E., Garbisa, S., Grigioni, W.F., Liotta, L. A., and Stetler-Stevenson, W.G. (1991). Increased expression of the Mr 72,000 type IV collagenase in human colonie adenocarcinoma. Cancer Res. 51, 439-444.
32. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. (1992). The origin and function of tumor-associated macrophages. Immunol. Today 13, 265-270.
33. Mantovani, A., Giavazzi, R., Polentarutti, N., Spreafico, F., and Garattini, S. (1980). Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice. Int. J. Cancer 25, 617-620.
34. Matrisian, L.M. (1992). The matrix-degrading metalloproteinases. BioEssays 14, 455-463.
35. Nathan, C.F. (1987). Secretory products of macrophages. J. Clin. Invest. 79, 319-326.
36. Normann, S.J. (1985). Macrophage infiltration and tumor progression. Cancer Metastasis Rev. 4, 277-291.
37. Ohlsson, K., and Olsson, I. (1974). Neutral proteases of human granulocytes, III: interaction between human granulocyte elastase and plasma protease inhibitors. Scand. J. Clin. Lab. Invest. 34, 349-355.
38. O'Reilly, M.S., Holmgren, L., Chen, C., and Folkman, J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689-692.
39. O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
40. Polverini, P.J. (1989). Macrophage-induced angiogenesis: a review. In Macrophage-derived Cell Regulatory Factors, C. Sorg, ed. (Basel: Karger), pp. 54-73.
41. Poste, G., and Fidler, U. (1980). The pathogenesis of cancer metastasis. Nature 283, 139-146.
42. Prehn, R.T. (1991). The inhibition of tumor growth by tumor mass. Cancer Res. 51, 2-4.
43. Prehn, R.T. (1993). Two competing influences that may explain concomitant tumor resistance. Cancer Res. 53, 3266-3269.
44. Senior, R.M., Griffin, G.L., Fliszar, C.J., Shapiro, S.D., Goldberg, G.I., and Welgus, H.G. (1991). Human 92-and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266, 7870-7875.
45. Shapiro, S.D., Griffin, G.L., Gilbert, D.J., Jenkins, N.A., Copeland, N.G., Welgus, H.G., Senior, R.M., and Ley, T.J. (1992). Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J. Biol. Chem. 267, 4664-4671.
46. Shapiro, S.D., Kobayashi, D.K., Pentland, A.P., and Welgus, H.G. (1993a). Induction of macrophage metalloproteinases by extracellular matrix: evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 268, 8170-8175.
47. Shapiro, S.D., Kobayashi, D.K., and Ley, T.J. (1993b). Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268, 23824-23829.
48. Shipley, J.M., Wesselschmidt, R.L., Kobayashi, D.K., Ley, T.J., and Shapiro, S.D. (1996a). Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA 93, 3942-3946.
49. Shipley, J.M., Doyle, G.A., Fliszar, C.J., Ye, Q.Z., Johnson, L.L., Shapiro, S.D., Welgus, H.G., and Senior, R.M. (1996b). The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases: role of the fibronectin type II-like repeats. J. Biol. Chem. 271, 4335-4341.
50. Shotton, D.M., and Hartley, B.S. (1970). Amino-acid sequence of porcine pancreatic elastase and its homologies with other serine proteinases. Nature 225, 802-806.
51. Sugarbaker, E.V., Thornthwaite, J., and Ketcham, A.S. (1977). Inhibitory effect of a primary tumor on metastasis. In Progress in Cancer Research and Therapy, S.B. Day, W.P.L. Myers, P. Stansly, S.Garrattini, and M.G. Lewis, eds. (New York: Raven Press), pp. 227-240.
52. Takeda, K., Fujii, N., Nitta, Y., Sakihara, H., Nakayama, K., Rikiishi, H., and Kumagai, K. (1991a). Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6. Jpn. J. Cancer Res. 82, 1299-1308.
53. Takeda, K., Hatakeyama, K., Tsuchiya, Y., Rikhshi, H., and Kumagai, K. (1991b). A correlation between GM-CSF gene expression and metastases in murine tumors. Int. J. Cancer 47, 413-420.
54. Talmadge, J.E., and Fidler, I.J. (1982). Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J. Natl. Cancer Inst. 69, 975-980.
55. Talmadge, J.E., Key, M.E., and Fidler, I.J. (1981). Macrophage content of metastatic and nonmetastatic rodent neoplasms. J. Immunol. 126, 2245-2248.
56. Tyzzer, E.E. (1913). Factors in the production and growth of tumor metastases. J. Med. Res. 25, 309-333.
57. Welgus, H.G., Campbell, E.J., Bar-Shavit, Z., Senior, R.M., and Teitelbaum, S.L. (1985). Human alveolar macrophages produce a fibroblast-likecollagenase and collagenase inhibitor. J. Clin. Invest. 76, 219-230.
58. Werb, Z., and Gordon, S. (1975). Elastase secretion by stimulated macrophages: characterization and regulation. J. Exp. Med. 142, 361-377.
59. Werb, Z., Banda, M.J., Takemura, R., and Gordon, S. (1986). Secreted proteins of resting and activated macrophages. In Handbook of Experimental Immunology, vol. 2: Cellular Immunology, D.M. Weir, C. Blackwell, and L.A. Herzenberg, eds. (Oxford: Blackwell Scientific), pp. 47.21-47.24.
60. Whitworth, P.W., Pak, C.C., Esgro, J., Kleinerman, E.S., and Fidler, I.J. (1990). Macrophages and cancer. Cancer Metastasis Rev. 8, 319-351.
61. Xie, B., Dong, Z., and Fidler, I.J. (1994). Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152, 3637-3644.
62. Young, M.R., Lozano, Y., Googan, M., Wright, M.A., Young, M.E., and Bagash, J.M. (1992). Stimulation of the metastatic properties of Lewis-lung-carcinoma cells by autologous granulocyte-macrophage colony-stimulating factor. Int. J. Cancer 50, 628-634.